Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A Randomized Controlled Pilot Trial: The Effects of EGb 761 on Information Processing and Executive Function in Multiple Sclerosis.
[Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital].
White matter disease: Early treatment of inflammatory demyelinating disease.
Fingolimod therapy for multiple sclerosis.
How scientists fool themselves - and how they can stop.
Pregnancy Does Not Prove Neuroprotective for Women with MS Who Stop Taking Natalizumab
Frontrunners of T cell activation: Initial, localized Ca2+ signals mediated by NAADP and the type 1 ryanodine receptor.
Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases.
GABAergic Agonists Modulate the Glutamate Release from Frontal Cortex Synaptosomes of Rats with Experimental Autoimmune Encephalomyelitis.
Multi-channel registration of fractional anisotropy and T1-weighted images in the presence of atrophy: application to multiple sclerosis.
Association between smoking and cognitive impairment in multiple sclerosis.
Targeting the low-hanging fruit of neurodegeneration.
Nonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis.
Multiple sclerosis in the far north - incidence and prevalence in Nordland County, Norway, 1970¿2010.
Difference in Motor Fatigue between Patients with Stroke and Patients with Multiple Sclerosis: A Pilot Study.
Accuracy and Reproducibility of a Quantitative Magnetic Resonance Imaging Method for Concurrent Measurements of Tissue Relaxation Times and Proton Density.
Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis.
Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series.
Low Prevalence of Sleep Disorders in Demyelinating Disease in a Northern Tenerife Population.
Iron chelation in the treatment of neurodegenerative diseases.
Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM.
OGR1/GPR68 Modulates the Severity of Experimental Autoimmune Encephalomyelitis and Regulates Nitric Oxide Production by Macrophages.
Pediatric familial neuromyelitis optica in two sisters with long term follow-up.
Correlates of the timed 25 foot walk in a multiple sclerosis outpatient rehabilitation clinic.
Oxidative modification of blood serum proteins in multiple sclerosis after interferon or mitoxantrone treatment.
Pages
« first
‹ previous
…
490
491
492
493
494
495
496
497
498
…
next ›
last »